DE25722T1 - Monoklonaler antikoerper gegen menschliche zytotoxische und suppressor-t-zellen und verfahren zu dessen herstellung. - Google Patents

Monoklonaler antikoerper gegen menschliche zytotoxische und suppressor-t-zellen und verfahren zu dessen herstellung.

Info

Publication number
DE25722T1
DE25722T1 DE198080303272T DE80303272T DE25722T1 DE 25722 T1 DE25722 T1 DE 25722T1 DE 198080303272 T DE198080303272 T DE 198080303272T DE 80303272 T DE80303272 T DE 80303272T DE 25722 T1 DE25722 T1 DE 25722T1
Authority
DE
Germany
Prior art keywords
cells
monoclonal antibody
antibody according
hybridoma
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE198080303272T
Other languages
German (de)
English (en)
Inventor
Gideon Short Hills New Jersey Goldstein
Patrick Chung-Shu Bridgewater New Jersey Kung
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ortho Pharmaceutical Corp
Original Assignee
Ortho Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26758322&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE25722(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ortho Pharmaceutical Corp filed Critical Ortho Pharmaceutical Corp
Publication of DE25722T1 publication Critical patent/DE25722T1/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/948—Microorganisms using viruses or cell lines
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y10S530/809—Fused cells, e.g. hybridoma
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/868—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, or immunotolerance

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE198080303272T 1979-09-18 1980-09-17 Monoklonaler antikoerper gegen menschliche zytotoxische und suppressor-t-zellen und verfahren zu dessen herstellung. Pending DE25722T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7664279A 1979-09-18 1979-09-18
US06/082,515 US4364932A (en) 1979-09-18 1979-10-09 Monoclonal antibody to human cytotoxic and suppressor T cells and methods of preparing same

Publications (1)

Publication Number Publication Date
DE25722T1 true DE25722T1 (de) 1984-07-19

Family

ID=26758322

Family Applications (2)

Application Number Title Priority Date Filing Date
DE198080303272T Pending DE25722T1 (de) 1979-09-18 1980-09-17 Monoklonaler antikoerper gegen menschliche zytotoxische und suppressor-t-zellen und verfahren zu dessen herstellung.
DE8080303272T Expired DE3070669D1 (en) 1979-09-18 1980-09-17 Monoclonal antibody to human cytotoxic and suppressor t cells, and method of preparing it

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE8080303272T Expired DE3070669D1 (en) 1979-09-18 1980-09-17 Monoclonal antibody to human cytotoxic and suppressor t cells, and method of preparing it

Country Status (19)

Country Link
US (1) US4364932A (enExample)
EP (1) EP0025722B2 (enExample)
AU (1) AU537806B2 (enExample)
CA (1) CA1170593A (enExample)
DE (2) DE25722T1 (enExample)
DK (1) DK154566C (enExample)
ES (1) ES8200559A1 (enExample)
FI (1) FI75364C (enExample)
GR (1) GR70286B (enExample)
HK (1) HK23986A (enExample)
IE (1) IE50534B1 (enExample)
IL (1) IL61063A (enExample)
MY (1) MY8600515A (enExample)
NO (1) NO159884C (enExample)
NZ (1) NZ194982A (enExample)
PH (1) PH16567A (enExample)
PT (1) PT71814B (enExample)
SG (1) SG6386G (enExample)
YU (1) YU44411B (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4803262A (en) * 1979-10-09 1989-02-07 Ortho Pharmaceutical Corporation Hybrid cell line for producing monoclonal antibody to human cytotoxic and suppressor T cells, antibody, and methods
US4637983A (en) * 1979-10-09 1987-01-20 Ortho Pharmaceutical Corporation Hybrid cell line for producing monoclonal antibody to human cytotoxic and suppressor T cells, antibody, and methods
USRE32011E (en) * 1981-12-14 1985-10-22 Scripps Clinic And Research Foundation Ultrapurification of factor VIII using monoclonal antibodies
US4511662A (en) * 1982-06-18 1985-04-16 Bio-Rad Laboratories, Inc. Simultaneous assay for T and B lymphocyte populations and subpopulations
US4443427A (en) * 1982-06-21 1984-04-17 Sidney Farber Cancer Institute, Inc. Monoclonal antibody
US4524025A (en) * 1982-06-30 1985-06-18 E. I. Du Pont De Nemours And Company Hybridoma cell lines and monoclonal antibodies to theophylline
US4579827A (en) * 1983-03-11 1986-04-01 Sloan-Kettering Institute For Cancer Research Monoclonal antibodies to human gastrointestinal cancers and hybridoma method of production of the monoclonal antibodies
US4677056A (en) * 1983-08-18 1987-06-30 Sloan-Kettering Institute For Cancer Research Monoclonal antibody subsetting human helper and killer T-cells and method
US5130144B1 (en) * 1984-02-06 1995-08-15 Univ Johns Hopkins Human stem cells and monoclonal antibodies
US4965204A (en) * 1984-02-06 1990-10-23 The Johns Hopkins University Human stem cells and monoclonal antibodies
FR2560212B1 (fr) * 1984-02-24 1989-12-29 Unicet Anticorps monoclonaux contre l'interferon a2 et hybridomes produisant de tels anticorps
US4649106A (en) * 1984-06-01 1987-03-10 Dana-Farber Cancer Institute, Inc. Distinguishing subsets of human cells
JPS6179164A (ja) * 1984-09-26 1986-04-22 Amano Pharmaceut Co Ltd 抗原抗体反応の短縮方法
US5431897A (en) * 1985-04-19 1995-07-11 Sloan-Kettering Institute For Cancer Research Method of imaging colorectal carcinoma lesion and composition for use therein
EP0302894B1 (en) * 1986-04-28 1992-11-19 Endotronics Inc. Method of culturing leukocytes
US4970299A (en) * 1986-07-03 1990-11-13 Sloan-Kettering Institute For Cancer Research Monoclonal antibodies selective for prostate cancer
US5085985A (en) * 1987-11-12 1992-02-04 Becton Dickinson & Co. Monoclonal antibodies and their use in a method for monitoring subsets of activated T cells
US5601819A (en) * 1988-08-11 1997-02-11 The General Hospital Corporation Bispecific antibodies for selective immune regulation and for selective immune cell binding
EP1030865A2 (en) * 1997-11-13 2000-08-30 Schering Corporation Th2 CELL DEPLETION; COMPOSITIONS; METHODS
CA2310805A1 (en) 1997-11-24 1999-06-03 Johnson T. Wong Methods for treatment of hiv or other infections using a t cell or viral activator and anti-retroviral combination therapy
US7653260B2 (en) 2004-06-17 2010-01-26 Carl Zeis MicroImaging GmbH System and method of registering field of view
US8582924B2 (en) 2004-06-30 2013-11-12 Carl Zeiss Microimaging Gmbh Data structure of an image storage and retrieval system

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4196265A (en) * 1977-06-15 1980-04-01 The Wistar Institute Method of producing antibodies
US4172124A (en) * 1978-04-28 1979-10-23 The Wistar Institute Method of producing tumor antibodies
US4284412A (en) * 1979-07-13 1981-08-18 Ortho Diagnostics, Inc. Method and apparatus for automated identification and enumeration of specified blood cell subclasses

Also Published As

Publication number Publication date
NZ194982A (en) 1983-02-15
YU44411B (en) 1990-08-31
NO802751L (no) 1981-03-19
ES495165A0 (es) 1981-11-16
GR70286B (enExample) 1982-09-03
NO159884B (no) 1988-11-07
PT71814B (en) 1982-03-26
IL61063A (en) 1984-04-30
EP0025722A3 (en) 1981-11-04
SG6386G (en) 1986-11-21
IL61063A0 (en) 1980-11-30
EP0025722A2 (en) 1981-03-25
FI75364C (fi) 1988-06-09
AU6247680A (en) 1981-04-09
PT71814A (en) 1980-10-01
NO159884C (no) 1989-02-15
US4364932A (en) 1982-12-21
PH16567A (en) 1983-11-18
CA1170593A (en) 1984-07-10
YU239280A (en) 1984-04-30
DK154566C (da) 1989-04-17
DE3070669D1 (en) 1985-06-27
AU537806B2 (en) 1984-07-12
FI75364B (fi) 1988-02-29
FI802917A7 (fi) 1981-03-19
EP0025722B1 (en) 1985-05-22
EP0025722B2 (en) 1999-04-14
ES8200559A1 (es) 1981-11-16
DK394880A (da) 1981-03-19
IE50534B1 (en) 1986-05-14
DK154566B (da) 1988-11-28
MY8600515A (en) 1986-12-31
HK23986A (en) 1986-04-11
IE801944L (en) 1981-03-18

Similar Documents

Publication Publication Date Title
DE25722T1 (de) Monoklonaler antikoerper gegen menschliche zytotoxische und suppressor-t-zellen und verfahren zu dessen herstellung.
DE30450T1 (de) Hybridzellinie zur herstellung komplementfixierender monoklonaler antikoerper gegen menschliche suppressor-t-zellen
DE18795T1 (de) Einen monoklonalen antikoerper produzierende hybridzellinie, antikoerper und verfahren zu seiner herstellung, diesen antikoerper enthaltende therapeutische zusammensetzung und deren diagnostische und therapeutische verwendungen.
DE18794T1 (de) Monoklonaler antikoerper gegen menschliche helfer-t-zellen, verfahren zu seiner herstellung, ihn produzierende hybridzellinie, seine diagnostischen und therapeutischen verwendungen und diesen antikoerper enthaltende diagnostische und therapeutische zusammensetzungen.
DE30815T1 (de) Hybridzellinie zur herstellung monoklonaler antikoerper gegen ein menschliches prothymozyt-antigen
DE33578T1 (de) Hybridzellinie zur herstellung monoklonaler antikoerper gegen ein menschliches t-zellen-antigen, antikoerper und verfahren.
DE30449T1 (de) Hybridzellinie zur herstellung monoklonaler antikoerper gegen ein menschliches thymozyt-antigen, antikoerper und verfahren zu seiner herstellung, diagnostische und therapeutische verwendungen und diesen antikoerper enthaltende pharmazeutische zusammensetzungen.
DE30814T1 (de) Hybridzellinie zur herstellung monoklonaler antikoerper gegen ein menschliches fruehes thymozyt-antigen
EP0531300B1 (de) Variante cd44-oberflächenproteine, diese kodierende dna-sequenzen, antikörper gegen diese proteine sowie ihre verwendung in der diagnostik und therapie
US7666417B2 (en) Methods and compositions for treating autoimmune diseases or conditions
DE69124387T3 (de) Rahmenbau-mutierte antikörper und ihre herstellung
DE33579T1 (de) Hybridzellinie zur herstellung monoklonaler antikoerper gegen ein menschliches monozyt-antigen, antikoerper und verfahren.
DE3888172T2 (de) Rekombinant-antikörper.
DE69133200T2 (de) Spezifisch bindende Agentien
DE69226990T2 (de) Tumorantigen-spezifischer Antikörper
DE17381T1 (de) Monoklonaler antikoerper gegen menschliche t-zellen, verfahren zu seiner herstellung, ihn produzierende hybridzellinie, ihn enthaltende therapeutische zusammensetzung und ihn verwendendes diagnostisches verfahren.
JP2008253267A (ja) 改変抗体可変領域の調製のための物質ならびにその治療的用途
DE186833T1 (de) Zytotoxisches protein, verfahren zum isolieren desselben, monoklonaler antikoerper ct-1 und denselben erzeugendes hybridoma.
DE3889062T2 (de) Monoklonaler Antikörper gegen humanen BCDF.
EP0241811A2 (de) Monoclonale Antikörper auf human-Interleukin-2-Rezeptor
DE3853481T2 (de) Fv Antikörperfragment-Herstellung.
DE163141T1 (de) Monoklonaler menschlicher anti-igg-koerper und verfahren zu seiner herstellung.
DE69019410T2 (de) Retinoblastoma-Genprodukt-Antikörper und deren Verwendungen.
Baran et al. Characterization of the soluble murine IL-2R and estimation of its affinity for IL-2.
DE3850993T2 (de) Monoklonaler Antikörper spezifisch gegen humane Pankreas-Phospholipase-A2.